Artiva Biotherapeutics, Inc. (ARTV) Dividend History
Artiva Biotherapeutics, Inc. is a biotechnology company focused on developing off-the-shelf natural killer (NK) cell therapies for cancer treatment. The company aims to leverage its proprietary platforms to create innovative immunotherapies that enhance the body's immune response against tumors. Founded with a focus on advancing cell therapy technologies, Artiva is dedicated to addressing unmet needs in oncology.
Dividend History
Artiva Biotherapeutics, Inc. currently does not pay dividends